Heart failure drug titration, discontinuation, mortality and heart failure hospitalization risk: a multinational observational study ( US , UK and Sweden)-Reference-Cited by-同舟云学术

Heart failure drug titration, discontinuation, mortality and heart failure hospitalization risk: a multinational observational study ( US , UK and Sweden)

Published:2021-06-28 Issue:9 Volume:23 Page:1499-1511
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Savarese Gianluigi¹,Bodegard Johan²,Norhammar Anna³,Sartipy Peter²⁴,Thuresson Marcus⁵,Cowie Martin R.⁶⁷,Fonarow Gregg C.⁸,Vaduganathan Muthiah⁹,Coats Andrew J.S.¹⁰¹¹¹²¹³

Affiliation:

1. Division of Cardiology, Department of Medicine Karolinska Institute, and Heart and Vascular Theme, Karolinska University Hospital Stockholm Sweden

2. AstraZeneca Gothenburg Sweden

3. Cardiology Unit, Department of Medicine Solna, Karolinska Institute Stockholm Sweden

4. Systems Biology Research Center, School of Bioscience, University of Skövde Skövde Sweden

5. Statisticon Uppsala Sweden

6. Faculty of Lifesciences & Medicine King's College London London UK

7. Division of Guy's & St Thomas' NHS Foundation Trust Royal Brompton Hospital London UK

8. Division of Cardiology, David Geffen School of Medicine University of California, Los Angeles Medical Center Los Angeles CA USA

9. Cardiovascular Division Brigham and Women's Hospital Boston MA USA

10. University of Warwick Coventry UK

11. Monash University Clayton Australia

12. Pharmacology, Centre of Clinical and Experimental Medicine, IRCCS San Raffaele Pisana Rome Italy

13. St George's University of London London UK

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.2271

Reference57 articles.

1. A Comparison of Enalapril with Hydralazine–Isosorbide Dinitrate in the Treatment of Chronic Congestive Heart Failure

2. Effects of Controlled-Release Metoprolol on Total Mortality, Hospitalizations, and Well-being in Patients With Heart Failure

3. The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure

4. Effect of Carvedilol on Survival in Severe Chronic Heart Failure

5. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In-hospital initiation of sodium-glucose cotransporter-2 inhibitors in patients with heart failure and reduced ejection fraction: 90-day prescription patterns and clinical implications;Current Problems in Cardiology;2024-10

2. Implementation of guideline-directed medical therapy for heart failure patients with reduced ejection fraction in Belgium: a Delphi panel approach;Acta Cardiologica;2024-09-10

3. Characteristics, Treatment, and Prognosis in Octogenarian and Older Patients With Acute Heart Failure in Japan　― Prospective Observational Study on Acute Pharmacotherapy and Prognosis in Management of Acute Heart Failure (POPEYE-AHF Registry) ―;Circulation Journal;2024-09-06

4. Evaluation of a virtual home health heart failure program: A mixed methods study (Preprint);2024-07-30

5. Pilot trial of an electronic decision support to improve care for emergency department patients with acute heart failure;ESC Heart Failure;2024-07-25